Attached files

file filename
10-Q/A - AMENDMENT NO. 1 TO FORM 10-Q - Adverum Biotechnologies, Inc.d362971d10qa.htm
EX-31.1 - EX-31.1 - Adverum Biotechnologies, Inc.d362971dex311.htm
EX-10.1 - EX-10.1 - Adverum Biotechnologies, Inc.d362971dex101.htm

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

I, Leone Patterson, certify that:

 

1. I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q of Adverum Biotechnologies, Inc. (formerly Avalanche Biotechnologies, Inc.);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Date: April 5, 2017

 

/s/ Leone Patterson

Leone Patterson

Chief Financial Officer

(principal financial and accounting officer)